Literature DB >> 17987343

Limitations of claims and registry data in surgical oncology research.

Hari Nathan1, Timothy M Pawlik.   

Abstract

Studies based on large population-based data sets, such as administrative claims data and tumor registry data, have become increasingly common in surgical oncology research. These data sets can be acquired relatively easily, and they offer larger sample sizes and improved generalizability compared with institutional data. There are, however, significant limitations that must be considered in the analysis and interpretation of such data. Invalid conclusions can result when insufficient attention is paid to issues such as data quality and depth, potential sources of bias, missing data, type I error, and the assessment of statistical significance. This article reviews some important limitations of population-based data sets and the methods used to analyze them. The candid reporting of these issues in the literature and an increased awareness among surgical oncologists of these limitations will ensure that population-based studies in the surgical oncology literature achieve high standards of methodological quality and clinical utility.

Entities:  

Mesh:

Year:  2007        PMID: 17987343     DOI: 10.1245/s10434-007-9658-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  62 in total

1.  Large variations in Medicare payments for surgery highlight savings potential from bundled payment programs.

Authors:  David C Miller; Cathryn Gust; Justin B Dimick; Nancy Birkmeyer; Jonathan Skinner; John D Birkmeyer
Journal:  Health Aff (Millwood)       Date:  2011-11       Impact factor: 6.301

2.  Sex disparities in cancer mortality and survival.

Authors:  Michael B Cook; Katherine A McGlynn; Susan S Devesa; Neal D Freedman; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-12       Impact factor: 4.254

3.  Racial disparity in surgical mortality after major hepatectomy.

Authors:  Hari Nathan; Wayne Frederick; Michael A Choti; Richard D Schulick; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2008-06-02       Impact factor: 6.113

4.  Clinical outcomes for neuroendocrine tumors of the duodenum and ampulla of Vater: a population-based study.

Authors:  Reese W Randle; Shuja Ahmed; Naeem A Newman; Clancy J Clark
Journal:  J Gastrointest Surg       Date:  2013-10-10       Impact factor: 3.452

5.  Racial disparities and patterns of ovarian cancer surgical care in California.

Authors:  F W Liu; L M Randall; K S Tewari; R E Bristow
Journal:  Gynecol Oncol       Date:  2013-09-07       Impact factor: 5.482

6.  Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database.

Authors:  Clancy J Clark; Christina M Wood-Wentz; Kaye M Reid-Lombardo; Michael L Kendrick; Marianne Huebner; Florencia G Que
Journal:  HPB (Oxford)       Date:  2011-09       Impact factor: 3.647

7.  Depressive symptoms in older long-term colorectal cancer survivors: a population-based analysis using the SEER-Medicare healthcare outcomes survey.

Authors:  Clancy J Clark; Nora F Fino; Jia Hao Liang; David Hiller; Jaime Bohl
Journal:  Support Care Cancer       Date:  2016-04-23       Impact factor: 3.603

8.  Impact of Delta Hemoglobin on Provider Transfusion Practices and Post-operative Morbidity Among Patients Undergoing Liver and Pancreatic Surgery.

Authors:  Gaya Spolverato; Fabio Bagante; Matthew Weiss; Jin He; Christopher L Wolfgang; Fabian Johnston; Martin A Makary; Will Yang; Steven M Frank; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2016-09-30       Impact factor: 3.452

9.  How Registry Data Will Change Our Approach to Lymphedema Research and Clinical Management.

Authors:  Nicole L Stout
Journal:  Rehabil Oncol       Date:  2018-01

10.  Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005.

Authors:  M B Cook; W-H Chow; S S Devesa
Journal:  Br J Cancer       Date:  2009-08-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.